Sedation in Head Injury
In patients with head injury requiring sedation, use continuous infusions of propofol or benzodiazepines (midazolam) as first-line agents, maintaining adequate cerebral perfusion pressure ≥60 mmHg while avoiding bolus dosing and hypotension. 1, 2
Primary Sedation Strategy
Propofol is the preferred agent for sedation in head-injured patients due to its ability to decrease intracranial pressure (ICP) by 46% while maintaining mean arterial pressure, and it demonstrates preserved flow-metabolism coupling. 3 The FDA label confirms propofol controlled ICP while maintaining cerebral perfusion pressure in neurosurgical ICU patients. 3
Propofol Dosing and Administration
- Initiate at 27 mcg/kg/min (mean maintenance rate across ICU studies), with a range of 2.8-130 mcg/kg/min titrated to effect 3
- Lower doses required in patients >55 years: approximately 20 mcg/kg/min versus 38 mcg/kg/min in younger patients 3
- Use continuous infusion only—never bolus doses, as boluses cause decreased blood pressure and compromised cerebral perfusion pressure 4, 3
- Monitor with processed EEG (such as BIS monitoring) when neuromuscular blockade is used to ensure adequate depth of sedation 1, 2
Critical Propofol Precautions
- Expect 15-20% decrease in blood pressure during initiation, particularly in the first 60 minutes 3
- Have vasopressors immediately available (phenylephrine or norepinephrine) rather than relying on fluid resuscitation alone 4
- Large doses (>4 mcg/mL plasma concentration) impair cerebrovascular autoregulation from 54% to 28%, potentially increasing vulnerability to secondary insults 5
- Contraindicated in pediatric ICU sedation due to increased mortality (11% vs 4% with standard sedatives) 3
Alternative Sedation Options
Midazolam (Benzodiazepines)
- Comparable efficacy to propofol with similar S100beta markers of neurological injury and equivalent neurological outcomes at 3 months 6
- Causes moderate decrease in cerebral metabolic rate and ICP with generally negligible side effects 1, 7
- May decrease mean arterial pressure through reduced central sympathetic drive, requiring blood pressure monitoring 7
Dexmedetomidine (Emerging Alternative)
- Dosing range: 0.2-1.0 mcg/kg/hr without initial bolus, or with bolus of 0.8-1.0 mcg/kg over 10 minutes 8
- Similar hemodynamic safety profile to standard sedation with transient bradycardia and hypotension episodes 8
- May reduce agitation episodes and alleviate sympathetic hyperactivity symptoms 8
- Allows for neurological assessment due to anxiolytic properties without deep sedation 8
Analgesia Management
Use continuous infusions of opioids—never bolus dosing—as bolus administration causes arterial hypotension catastrophic in TBI patients. 4
Opioid Selection and Dosing
- Fentanyl is first-line: causes hypotension in only 1.6% of trauma patients 4
- Morphine alternative: hypotension rate 0.5% but higher nausea/vomiting (4.8%) 4
- All opioid infusions require continuous blood pressure monitoring to maintain systolic BP >110 mmHg 4
Adjunctive Analgesia
- Intravenous acetaminophen every 6 hours is effective and used in 78% of TBI patients at discharge 4
- NSAIDs use with extreme caution due to acute kidney injury and gastrointestinal bleeding risks 4
- Ketamine may be considered (0.5% hypotension rate) but requires additional sedation 4
Absolute Contraindications
- Tramadol is absolutely contraindicated: reduces seizure threshold in patients already at high risk for post-traumatic seizures 4
- Mixed agonist-antagonist opioids (pentazocine, nalbuphine, butorphanol) precipitate withdrawal 4
Sedation Management Principles
Standard ICU Guidelines Apply with Modifications
Follow standard ICU sedation protocols for non-brain injured patients, except when treating intracranial hypertension or status epilepticus. 1, 2
- Daily interruption of sedation is potentially harmful in TBI patients with signs of high ICP on CT scan, as it may cause ICP elevation and cerebral metabolic stress 1, 2
- Light sedation protocols from general ICU populations do not apply during targeted temperature management or when controlling ICP 1
- Pain assessment using Behavioral Pain Scale (BPS) when patients cannot self-report with Numeric Rating Scale 1
Hemodynamic Targets During Sedation
Maintain cerebral perfusion pressure (CPP) ≥60 mmHg at all times, as even single episodes of hypotension (SBP <90 mmHg) markedly worsen outcomes. 2, 4
- Target systolic blood pressure >110 mmHg continuously 4
- Manage hypertension by increasing sedation first, then small boluses of labetalol 1
- Treat hypotension after correcting hypovolemia or excess sedation with alpha-agonist bolus followed by infusion (metaraminol or norepinephrine via central line) 1
Ventilation Parameters
- Target PaCO2 4.5-5.0 kPa (34-38 mmHg) during routine management 1
- Target PaO2 ≥13 kPa (≥98 mmHg) to avoid even brief hypoxic episodes 1
- Use PEEP 5-10 cmH2O: minimum 5 cmH2O prevents atelectasis, up to 10 cmH2O does not adversely affect cerebral perfusion 1
Management of Raised ICP During Sedation
First-Tier ICP Control
- Head of bed elevation 20-30° to assist venous drainage 1, 2
- Bolus of sedative drugs (propofol or midazolam) as immediate intervention 1
- Maintain adequate sedation and analgesia following protocols with modifications for ICP control 1, 2
Second-Tier ICP Control
- Mannitol 0.5 g/kg infused over 15-20 minutes 1, 9
- Hypertonic saline 2 mL/kg of 3% saline (250 mOsm) over 15-20 minutes 1, 9
- Temporary hyperventilation (PaCO2 not less than 4 kPa/30 mmHg) only for impending herniation as bridge to definitive therapy 1, 2
Common Pitfalls to Avoid
- Never use bolus dosing of sedatives or opioids: causes hemodynamic instability and compromised cerebral perfusion 4, 3
- Never implement daily sedation interruption protocols in patients with radiological signs of high ICP 1, 2
- Never delay vasopressor use while attempting fluid resuscitation alone in hypotensive patients 4
- Never use hypotonic fluids (Ringer's lactate, Ringer's acetate, gelatins): only 0.9% saline is isotonic by osmolality 1
- Never assume opioids are contraindicated: uncontrolled pain increases ICP and metabolic stress 4
- Never use high-dose barbiturate "coma" routinely: reserved only for refractory ICP with preserved CO2 reactivity 7
- Never use propofol for pediatric ICU sedation in head injury due to increased mortality risk 3